search
Back to results

Evaluation of the Impact of Tractions vs. Placebo Tractions in Patients With Cervical Radiculopathy (TracCerv2)

Primary Purpose

Radiculopathy, Cervical

Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Intensive cervical traction protocol
Intensive cervical traction protocol - placebo
Sponsored by
Centre Hospitalier Departemental Vendee
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Radiculopathy focused on measuring Cervical traction, Cervical radiculopathy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patient over 18 Neck Disability Index ≥ 15/50 Presence of at least three of the four signs clinically validating the presence of cervical radiculopathy (Wainner et al. 2003) a) upper limb nerve tension test A (ULNT1a): positive, b) amplitude of cervical rotation on the side concerned: < 60°, c) positive cervical distraction test: relief d) positive Spurling test: reproduction of symptoms. Cervical radiculopathy diagnosed 3 to 12 months previously Absence of cervical traction in the 5 years prior to inclusion MRI or CT scan performed prior to hospitalisation in relation to current pathology Patient able to understand the protocol and having given oral informed consent to take part in the research. Patient affiliated to the social security system or entitled beneficiary. Patient hospitalised during a week without public holidays. Exclusion Criteria: Patients with vertebral artery pathology at the time of inclusion Patients with myelopathy, cervical cancer, cervical fracture, cervical dislocation, cervical spondylolisthesis, spinal infection, symptomatic cervical pain without radiculopathy and/or cervical surgery in the 2 years prior to inclusion. Patient participating in another clinical research protocol with an impact on the objectives of the research. Patient who is pregnant, breastfeeding or able to procreate without effective contraception*. Patient under guardianship, curatorship or deprived of liberty Patient under activated future protection mandate Patient under family habilitation Patient under court protection.

Sites / Locations

  • CHD Vendée
  • CH La Rochelle
  • CH Emile Roux
  • CHU Limoges
  • CHU Nantes
  • APHP La Pitié Salpêtrière
  • CHU Rouen

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Placebo mechanical cervical traction

Mechanical cervical traction

Arm Description

Outcomes

Primary Outcome Measures

Patients with a Neck Disability Index (NDI) score reduction of at least 7 points at M3.
The minimum clinically important difference (MCID) was established at 7 points out of 50 by (Cleland et al. 2006).

Secondary Outcome Measures

Full Information

First Posted
July 11, 2023
Last Updated
July 19, 2023
Sponsor
Centre Hospitalier Departemental Vendee
search

1. Study Identification

Unique Protocol Identification Number
NCT05952167
Brief Title
Evaluation of the Impact of Tractions vs. Placebo Tractions in Patients With Cervical Radiculopathy
Acronym
TracCerv2
Official Title
Evaluation of the Impact of Tractions vs. Placebo Tractions in Patients With Cervical Radiculopathy, Randomised Controlled Trial in a Single-blind Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 1, 2023 (Anticipated)
Primary Completion Date
July 1, 2026 (Anticipated)
Study Completion Date
April 1, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Departemental Vendee

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Cervical radiculopathy is a common disease related to compression of the nerve roots of the spine (prevalence: 3.5/1000). Dysfunction and pain are the main repercussions and can lead to time off work and high costs in terms of treatment. Second-line surgical treatments appear to be less effective and present risks of side effects. In the first instance, treatments are conservative and include medication but above all physiotherapy with manual therapy, muscle exercises and cervical traction. These cervical tractions performed by a physiotherapist require little equipment and are inexpensive compared with the surgical alternative. They involve stretching the cervical spine and soft tissues to open the intervertebral foramen and mobilise the facet joints. Several authors have written summaries of their interest. Thoomes reports two studies and describes an absence of effect. In a meta-analysis, Romeo et al. added three more recent studies to the previous review and concluded that traction is effective, highlighting an "effect-dose" relationship. These recent results therefore seem to reverse the recommendations made barely two years later. Nevertheless, almost all the studies compared "manual therapy + exercises" with "manual therapy + exercises + cervical traction". Only Young et al. tested "manual therapy + exercises + cervical traction at an effective weight" compared to "manual therapy + exercises + cervical traction placebo at an ineffective weight". The study did not reveal any difference between the groups. However, several limitations appear in this study when comparing the protocol to studies that have shown efficacy. The main limitation is the low intensity (i.e. protocol with fewer sessions and longer duration). These clinical limitations may explain the lack of evidence of a positive outcome. Following on from a preliminary study evaluating an intensive cervical traction protocol over five days, and in order to discern the effect specific to the treatment (specific effect) and the effect independent of the nature of the treatment (contextual effect), the investigators wish to evaluate the impact of this intensive protocol by comparing it with placebo traction. In current practice, treatment varies between establishments. The paucity of studies on cervical traction in radiculopathy has resulted in routine use being guided by habit rather than evidence. It remains a clinical question which raises a major issue requiring a robust experimental design. Ultimately, this study follows on from a preliminary study and is part of a comprehensive research project aimed at proposing new recommendations for the use of traction in patients suffering from cervical radiculopathy. The investigators are investigating the impact of an intensive traction vs. placebo traction protocol in patients with cervical radiculopathy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Radiculopathy, Cervical
Keywords
Cervical traction, Cervical radiculopathy

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
206 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Placebo mechanical cervical traction
Arm Type
Placebo Comparator
Arm Title
Mechanical cervical traction
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Intensive cervical traction protocol
Intervention Description
2x/day over 5 weekdays without public holidays
Intervention Type
Other
Intervention Name(s)
Intensive cervical traction protocol - placebo
Intervention Description
2x/day over 5 weekdays without public holidays
Primary Outcome Measure Information:
Title
Patients with a Neck Disability Index (NDI) score reduction of at least 7 points at M3.
Description
The minimum clinically important difference (MCID) was established at 7 points out of 50 by (Cleland et al. 2006).
Time Frame
At 3 months post cervical traction protocol

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient over 18 Neck Disability Index ≥ 15/50 Presence of at least three of the four signs clinically validating the presence of cervical radiculopathy (Wainner et al. 2003) a) upper limb nerve tension test A (ULNT1a): positive, b) amplitude of cervical rotation on the side concerned: < 60°, c) positive cervical distraction test: relief d) positive Spurling test: reproduction of symptoms. Cervical radiculopathy diagnosed 3 to 12 months previously Absence of cervical traction in the 5 years prior to inclusion MRI or CT scan performed prior to hospitalisation in relation to current pathology Patient able to understand the protocol and having given oral informed consent to take part in the research. Patient affiliated to the social security system or entitled beneficiary. Patient hospitalised during a week without public holidays. Exclusion Criteria: Patients with vertebral artery pathology at the time of inclusion Patients with myelopathy, cervical cancer, cervical fracture, cervical dislocation, cervical spondylolisthesis, spinal infection, symptomatic cervical pain without radiculopathy and/or cervical surgery in the 2 years prior to inclusion. Patient participating in another clinical research protocol with an impact on the objectives of the research. Patient who is pregnant, breastfeeding or able to procreate without effective contraception*. Patient under guardianship, curatorship or deprived of liberty Patient under activated future protection mandate Patient under family habilitation Patient under court protection.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chloé MOREAU
Phone
0251446327
Ext
+33
Email
chloe.moreau@ght85.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas RULLEAU
Organizational Affiliation
Nantes University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHD Vendée
City
La Roche-sur-Yon
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Grégoire CORMIER
Facility Name
CH La Rochelle
City
La Rochelle
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ludivine LAURENT
Facility Name
CH Emile Roux
City
Le Puy-en-Velay
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Océane ROCHE
Facility Name
CHU Limoges
City
Limoges
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Julien COLLIN
Facility Name
CHU Nantes
City
Nantes
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joelle GLEMAREC
Facility Name
APHP La Pitié Salpêtrière
City
Paris
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bruno FAUTREL
Facility Name
CHU Rouen
City
Rouen
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Timotheé GILLOT

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluation of the Impact of Tractions vs. Placebo Tractions in Patients With Cervical Radiculopathy

We'll reach out to this number within 24 hrs